Johnson & Johnson to buy Synthes for $21.3bn
Johnson & Johnson is to buy Swiss medical devices maker Synthes in a deal worth $21.3bn, its largest ever buy, boosting its orthopaedics franchise and reshaping the medical technology industry.
Johnson & Johnson is in talks to buy Swiss medical device maker Synthes for $20 billion, according to a report on the Wall Street Journal website, citing people familiar with the matter.